PL1636348T3 - Sposób wytwarzania wysepkowych komórek beta z zewnątrzwydzielniczych komórek trzustkowych - Google Patents

Sposób wytwarzania wysepkowych komórek beta z zewnątrzwydzielniczych komórek trzustkowych

Info

Publication number
PL1636348T3
PL1636348T3 PL04737673T PL04737673T PL1636348T3 PL 1636348 T3 PL1636348 T3 PL 1636348T3 PL 04737673 T PL04737673 T PL 04737673T PL 04737673 T PL04737673 T PL 04737673T PL 1636348 T3 PL1636348 T3 PL 1636348T3
Authority
PL
Poland
Prior art keywords
cells
exocrine pancreatic
islet beta
pancreatic cells
generating islet
Prior art date
Application number
PL04737673T
Other languages
English (en)
Inventor
Luc Bouwens
Luc Baeyens
Original Assignee
Vrije Univ Brussel Vub
Opus Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vrije Univ Brussel Vub, Opus Nv filed Critical Vrije Univ Brussel Vub
Publication of PL1636348T3 publication Critical patent/PL1636348T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C12N2501/235—Leukemia inhibitory factor [LIF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/22—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from pancreatic cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL04737673T 2003-06-20 2004-06-21 Sposób wytwarzania wysepkowych komórek beta z zewnątrzwydzielniczych komórek trzustkowych PL1636348T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03447164 2003-06-20
PCT/BE2004/000089 WO2004113512A2 (en) 2003-06-20 2004-06-21 Method of generating islet beta-cells from exocrine pancreatic cells
EP04737673A EP1636348B1 (en) 2003-06-20 2004-06-21 Method of generating islet beta-cells from exocrine pancreatic cells

Publications (1)

Publication Number Publication Date
PL1636348T3 true PL1636348T3 (pl) 2010-01-29

Family

ID=33522524

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04737673T PL1636348T3 (pl) 2003-06-20 2004-06-21 Sposób wytwarzania wysepkowych komórek beta z zewnątrzwydzielniczych komórek trzustkowych

Country Status (13)

Country Link
US (1) US7604991B2 (pl)
EP (1) EP1636348B1 (pl)
JP (1) JP2007520194A (pl)
AT (1) ATE437941T1 (pl)
CA (1) CA2527626A1 (pl)
CY (1) CY1109474T1 (pl)
DE (1) DE602004022292D1 (pl)
DK (1) DK1636348T3 (pl)
ES (1) ES2330438T3 (pl)
PL (1) PL1636348T3 (pl)
PT (1) PT1636348E (pl)
SI (1) SI1636348T1 (pl)
WO (1) WO2004113512A2 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009103637A1 (en) * 2008-02-22 2009-08-27 Vrije Universiteit Brussel Method for generating islet beta cells from dedifferentiated exocrine pancreatic cells
KR102058259B1 (ko) 2012-06-26 2019-12-23 세라시스, 인코포레이티드 인슐린 의존성 당뇨병의 치료에 유용한 줄기 세포 및 췌장 세포
US9988605B2 (en) * 2013-12-11 2018-06-05 Korea Advanced Institute Of Science And Technology Method for preparing endocrine aggregate of insulin-producing beta cells from human pluripotent stem cells
US11466255B2 (en) 2015-05-01 2022-10-11 University Of Miami Methods and compositions for converting non-endocrine pancreatic tissue into insulin-producing cells
US10767164B2 (en) 2017-03-30 2020-09-08 The Research Foundation For The State University Of New York Microenvironments for self-assembly of islet organoids from stem cells differentiation

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2235509A1 (en) * 1995-10-25 1997-05-01 Ammon B. Peck In vitro growth of functional islets of langerhans and in vivo uses thereof
JP4624558B2 (ja) * 1998-08-10 2011-02-02 ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ， アズ レプレゼンテッド バイ ザ セクレタリー， デパートメント オブ ヘルス アンド ヒューマン サービシーズ ＧＬＰ−１またはＥｘｅｎｄｉｎ−４による、非インスリン産生細胞のインスリン産生細胞への分化、およびその使用
KR19990014353A (ko) * 1998-10-17 1999-02-25 윤태욱 췌도의 대량 배양증식방법
US6815203B1 (en) * 1999-06-23 2004-11-09 Joslin Diabetes Center, Inc. Methods of making pancreatic islet cells
WO2001032839A2 (en) 1999-10-29 2001-05-10 Mcgill University Medium for preparing dedifferentiated cells
US6610535B1 (en) * 2000-02-10 2003-08-26 Es Cell International Pte Ltd. Progenitor cells and methods and uses related thereto
PT1146117E (pt) 2000-04-12 2008-05-06 Beta Cell N V Um método para a produção de preparações de células endócrinas pancreáticas maduras e imaturas, a preparação de células e seu uso para tratamento de diabetes mellitus
FR2814752A1 (fr) * 2000-10-02 2002-04-05 Chru Lille Procede d'obtention in vitro de cellules insulino- secretrices de mammifere et leurs utilisations
US20060122104A1 (en) * 2002-05-28 2006-06-08 Presnell Sharon C Methods for in vitro expansion and transdifferentiation of human pancreatic acinar cells into insulin-producing cells

Also Published As

Publication number Publication date
ATE437941T1 (de) 2009-08-15
EP1636348B1 (en) 2009-07-29
JP2007520194A (ja) 2007-07-26
US7604991B2 (en) 2009-10-20
EP1636348A2 (en) 2006-03-22
WO2004113512A3 (en) 2005-03-31
PT1636348E (pt) 2009-10-21
CY1109474T1 (el) 2014-08-13
DK1636348T3 (da) 2009-11-23
WO2004113512A2 (en) 2004-12-29
ES2330438T3 (es) 2009-12-10
SI1636348T1 (sl) 2010-01-29
US20070292388A1 (en) 2007-12-20
CA2527626A1 (en) 2004-12-29
DE602004022292D1 (de) 2009-09-10

Similar Documents

Publication Publication Date Title
WO2005086860A3 (en) Methods for generating insulin-producing cells
GB2442406A (en) Mesoderm and definitive endoderm cell populations
SE0003508D0 (sv) Behandling av diabetes
Abdelalim et al. Advances and challenges in the differentiation of pluripotent stem cells into pancreatic β cells
CY1109474T1 (el) Μεθοδος δημιουργιας β-κυτταρων νησιδιων απο ενδοκρινη παγκρεατικα κυτταρα
IN2014DN10053A (pl)
SG152273A1 (en) Pdx1 expressing endoderm
GEAP202315908A (en) Polyheterocyclic modulators of sting (stimulator of interferon genes)
CA2470539A1 (en) Islet cells from human embryonic stem cells
WO2008124169A3 (en) Islet cells composition and methods
TW200943454A (en) Apparatus for treating substrate
MX2008007286A (es) Ingenieria in vivo de superficie celular.
SG11201809400UA (en) Purification method for pancreatic precursor cells derived from pluripotent stem cells and amplification method therefor
SG141296A1 (en) Mesoderm and definitive endoderm cell populations
SA522432641B1 (ar) T تركيبة لزراعة الخلية التنظيمية واستخدامها
MX2019009886A (es) Composiciones y metodos para utilizar peptidos de neogenesis de islote y analogos de los mismos.
WO2002029010A3 (fr) Procede d'obtention in vitro de cellules insulino-secretrices de mammifere et leurs utilisations
WO2005094353A3 (en) Methods for production of regulatory t cells and uses thereof
TW200503619A (en) Use of isoindolinone derivatives as insecticides
MX2010012730A (es) Metodo para diferenciacion de celulas progenitoras de mamifero en celulas de islote pancreaticas que producen insulina.
WO2009062260A8 (en) Therapy for multiple sclerosis
EP4257143A3 (en) Methods and compositions for treatment of type 1 diabetes using fibroblasts as facilitators of islet engraftment
TW200602044A (en) Compounds
IL145674A (en) Use of heregulin in the preparation of a medicament for treating pancreatic dysfunction
IL164250A0 (en) Chimeric pancreas